QT prolongation is associated with increased mortality in end stage liver disease

doi:10.4330/wjc.v9.i4.347

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6914)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

528

WORD

240

HTML

3867

Figures (1-3)

140

Tables (1-2)

135

Sum=4910

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

894

Download

1108

Sum=2002

Apr 26, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. Apr 26, 2017; 9(4): 347-354
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.347

Full Size Figure Download Figure

Figure 1 Association of mortality with Model for End-Stage Liver Disease components and clinical variables.

Citation: Kim SM, George B, Alcivar-Franco D, Campbell CL, Charnigo R, Delisle B, Hundley J, Darrat Y, Morales G, Elayi SC, Bailey AL. QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol 2017; 9(4): 347-354
URL: https://www.wjgnet.com/1949-8462/full/v9/i4/347.htm
DOI: https://dx.doi.org/10.4330/wjc.v9.i4.347